Literature DB >> 6313408

Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines.

N Sidell, A Altman, M R Haussler, R C Seeger.   

Abstract

It has been shown that retinoic acid (RA) can promote morphologic differentiation and inhibit the growth of a human neuroblastoma cell line, LA-N-1. The present study tests the histological generality of these phenomena by determining the effects of RA on seven other human neuroblastoma cell lines. Results show that RA strongly inhibited anchorage-dependent growth and induced morphologic alterations in six of seven of the cell lines. These alternations included morphologic differentiation as evidenced by formation of neurite extensions in four of the lines, cellular enlargement and vacuolization in one culture, and formation of large, flattened epithelial or fibroblastic-like cells in another culture. Although one cell line was relatively insensitive to the effects of RA in monolayer culture, all seven were strongly inhibited by RA in soft agar assays. Cellular RA-binding proteins were detected in 2/2 lines tested. These findings suggest that, as a histological group, human neuroblastoma cells are extremely sensitive to RA-induced growth inhibition and morphological alterations generally associated with reduced expression of the malignant phenotype of this type of cancer.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313408     DOI: 10.1016/0014-4827(83)90184-2

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  74 in total

1.  Effect of retinoic acid on the Ca2+-independent phospholipase A2 in nuclei of LA-N-1 neuroblastoma cells.

Authors:  P Antony; L Freysz; L A Horrocks; A A Farooqui
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

2.  A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse.

Authors:  L Conforti; A Tarlton; T G Mack; W Mi; E A Buckmaster; D Wagner; V H Perry; M P Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  Vitronectin expression in differentiating neuroblastic tumors: integrin alpha v beta 5 mediates vitronectin-dependent adhesion of retinoic-acid-differentiated neuroblastoma cells.

Authors:  C L Gladson; C Dennis; T C Rotolo; D R Kelly; J R Grammer
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

4.  Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma.

Authors:  Raoud Marayati; Adele P Williams; Laura V Bownes; Colin H Quinn; Jerry E Stewart; Elizabeth Mroczek-Musulman; Venkatram R Atigadda; Elizabeth A Beierle
Journal:  J Pediatr Surg       Date:  2020-02-28       Impact factor: 2.545

5.  DNA replication and postreplication mismatch repair in cell-free extracts from cultured human neuroblastoma and fibroblast cells.

Authors:  P David; E Efrati; G Tocco; S W Krauss; M F Goodman
Journal:  J Neurosci       Date:  1997-11-15       Impact factor: 6.167

6.  Nav2 is necessary for cranial nerve development and blood pressure regulation.

Authors:  Elizabeth M McNeill; Kenneth P Roos; Dieder Moechars; Margaret Clagett-Dame
Journal:  Neural Dev       Date:  2010-02-25       Impact factor: 3.842

7.  Phosphatidylcholine biosynthesis during neuronal differentiation and its role in cell fate determination.

Authors:  Hebe Marcucci; Luciana Paoletti; Suzanne Jackowski; Claudia Banchio
Journal:  J Biol Chem       Date:  2010-06-05       Impact factor: 5.157

8.  Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.

Authors:  Robin E Norris; Jane E Minturn; Garrett M Brodeur; John M Maris; Peter C Adamson
Journal:  Cancer Chemother Pharmacol       Date:  2011-04-12       Impact factor: 3.333

9.  3,4-dihydroxyphenylalanine (dopa) metabolism and retinoic acid induced differentiation in human neuroblastoma.

Authors:  H Ikeda; A Pastuszko; N Ikegaki; R H Kennett; D F Wilson
Journal:  Neurochem Res       Date:  1994-12       Impact factor: 3.996

10.  Expression of CD44 is repressed in neuroblastoma cells.

Authors:  E Shtivelman; J M Bishop
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.